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Abstract 
Rapid decontamination is vital to alleviate adverse health effects following dermal exposure 
to hazardous materials. There is an abundance of materials and products which can be utilised 
to remove hazardous materials from the skin. In this study, a total of 15 products were 
evaluated, 10 of which were commercial or military products and 5 were novel (molecular 
imprinted) polymers. The efficacies of these products were evaluated against a 10µL droplet 
of 14C-methyl salicylate applied to the surface of porcine skin mounted in static diffusion 
cells. The current UK military decontaminant (Fuller’s earth) performed well, retaining 83% 
of the dose over 24 hours and served as a benchmark to compare with the other test products. 
The five most effective test products were Fuller’s earth (the current UK military 
decontaminant), Fast-Act® and three novel polymers (based on itaconic acid, 2-
trifluoromethylacrylic acid and N,N-methylene bis acrylamide).  Five products (medical 
moist-free wipes, 5% FloraFree™ solution, normal baby-wipes, baby-wipes for sensitive skin 
and Diphotérine) enhanced the dermal absorption of 14C-methyl salicylate.  Further work is 
required to establish the performance of the most effective products identified in this study 
against chemical warfare agents. 
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Introduction 
The deliberate release of chemical, biological, radiological and nuclear (CBRN) materials 
poses a significant threat to civilian populations as exemplified by the 1995 Tokyo sarin 
incident (1). Skin decontamination of civilians following exposure to hazardous materials is 
vital to mitigate local or systemic absorption and subsequent toxicity. Current UK mass 
casualty decontamination procedures require the casualty to disrobe and decontaminate 
within bespoke showering units. This procedure has many logistical issues such as time taken 
to erect the shower units, potential crowd management issues and triage of casualties which 
may delay decontamination (2, 3). Moreover, previous studies have shown that water may 
enhance the penetration of certain chemicals through the skin via the ‘wash-in effect’ (4-7). 
Within the current procedure there is a window in which to perform rapid decontamination 
prior to or in lieu of showering within the bespoke showering units. Therefore, the 
identification or development of an effective decontamination product which can be used at 
the scene of an incident by members of the public may represent a significant improvement 
for managing mass casualty incidents requiring decontamination. Clearly, such products need 
to be evaluated to ensure their effectiveness against a range of toxic chemicals. 
Methyl salicylate is generally regarded as an appropriate chemical warfare agent simulant for 
sulphur mustard (bis(2-chloroethyl) sulphide) based upon its physiochemical properties and 
dermal absorption kinetics (8). It has been applied in various scenarios from evaluating 
medical countermeasures to assessment of protective clothing (9-13).  
The purpose of this study was to identify an effective product which can be rapidly deployed 
at the scene of a CBRN incident prior to the availability of bespoke decontamination 
facilities. A range of products were selected for evaluation: Commercial- off- the- shelf 
(COTS) products were selected on the basis of suppliers’ claims of efficacy; some were 
chosen as they may be readily available (such as baby-wipes). Novel polymers were selected 
based upon their binding affinities to methyl salicylate, sulphur mustard, soman and VX 
which was determined by in silico modelling using the LEAPFROG algorithm. Military 
products were chosen on the basis that they may serve as a benchmark of ‘standard efficacy’ 
and also to evaluate their efficacy against the chemical warfare agent simulant methyl 
salicylate. 
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Materials and Methods 
Ring-labelled (14C) methyl salicylate (55 mCi mMol-1) was purchased from ARC (UK) Ltd 
(Cardiff, UK). Non-radioactive methyl salicylate (MS) was purchased from Sigma Aldrich 
(Poole, UK) and was reported to be >99% pure. These were mixed in an appropriate 
proportion to give a working solution with a nominal activity of 0.2 µCi µl-1. 
Soluene®-350 and Ultima Gold™ liquid scintillation counting (LSC) fluid were purchased 
from PerkinElmer, Cambridgeshire, UK. Propan-2-ol and ethanol were obtained from Fisher 
Scientific, Leicestershire, UK. 
Proprietary products obtained for evaluation were Fuller’s earth (Sigma Aldrich, Poole, UK), 
KBDO (potassium butadiene monoximate) liquid (E-Z-EM Inc., Canada; free-flow bottle and 
sponge formulations), normal baby wipes (‘Pampers baby fresh’, Proctor & Gamble), 
Diphotérine eye wash (Prevor, Valmondois, France), Fast Act chemical containment and 
neutralisation system (NanoScale, Manhattan, USA), FloraFree detergent (DEB Ltd, Belper, 
UK), alcohol free medical wipes (Safety First Aid Group, London, UK) and an industrial skin 
decontamination cream (DTAM SKIN™, Colormetric Laboratories Inc., Illinois, USA). 
Novel polymers were prepared by the University of Cranfield (Cranfield, UK) as previously 
described in a patent (14). The materials were synthesised using ethylene glycol 
dimethacrylate (EGDMA) cross-linker and various monomers which confer different 
functional groups (e.g. amide, amine, carboxylate) to the resulting polymer. The cross-linker 
and functional monomer were mixed in a 4:1 molar ratio with a free-radical initiator (1, 1'-
azobis(cyclohexanecarbonitrile), 1% w/w of total mixture) which decomposes under UV light 
or heat. Dimethylformamide (DMF, volume equivalent to the combined mass of reactants) 
was used as solvent and porogen. The monomers, initiator and solve t were mixed in a glass 
bottle and degassed with nitrogen for 5 minutes. The bottle was then sealed with a screw cap 
and the reaction initiated by heating to 80 °C for 18 hours. Control polymers were prepared 
with EGDMA in the absence of any functional monomers. Following polymerisation, the 
resulting material was ground then wet-sieved with methanol to collect particles ranging from 
40 to 90 µm diameter which were subsequently washed with hot methanol for 24 hours and 
dried at 80 ºC overnight. 
Full thickness skin was obtained post mortem from female pigs (Sus scrofa, large white 
strain, weight range 15-25 kg) purchased from a reputable supplier. The skin was close 
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clipped and excised from the dorsal aspect (full thickness) from each animal. The skin was 
then wrapped in aluminium foil and stored flat at -20ºC for up to 3 months before use. Prior 
to the commencement of each experiment, a skin sample from one animal was removed from 
cold storage and thawed in a refrigerator (5ºC) for approximately 24 hours. The skin was then 
dermatomed to a nominal depth of 500 µm using a Humeca Model D42, (Eurosurgical Ltd, 
Guildford, UK) and the thickness of the resulting skin section confirmed using a digital 
micrometer gauge (Tooled-Up, Middlesex, UK). Once dermatomed, the skin was cut into 
squares (3 x 3 cm) in preparation for mounting onto diffusion cells. 
Static skin diffusion cells were purchased from PermeGear (Chicago, Illinois, USA) and 
based upon the design of the Franz diffusion cell (15). Each diffusion cell comprised an upper 
(donor) and lower (receptor) chamber with an area available for diffusion of 1.76 cm2. 
Dermatomed skin sections were placed between the two chambers (epidermal surface facing 
the donor chamber) and the ensemble was securely clamped. The receptor chambers were 
filled with 50% (v/v) aqueous ethanol (approximately 14 ml ± 0.8 ml), so that the meniscus in 
the sampling arm was level with the surface of the skin sample. Each diffusion cell was 
placed in a Perspex™ holder above a magnetic stirrer which constantly mixed the receptor 
fluid via a (12 x 6 mm) Teflon™-coated iron bar placed within the receptor chamber. The 
receptor chambers were of the jacketed variety through which warm (36ºC) water was 
pumped from a circulating water heater (Model GD120, Grant Instruments, Cambridge, UK) 
via a manifold to ensure a constant skin surface temperature of 32ºC (as confirmed by 
infrared thermography; FLIR Model P620 camera, Cambridge, UK). Once assembled, the 
diffusion cells were left in situ for an equilibration period of up to 24 hours. 
Thirty six diffusion cells were used in each experiment, divided into to six treatment groups 
(each comprising n=6 diffusion cells). Each experiment was initiated by the addition of 10 µl 
14C-radiolabelled methyl salicylate (MS; 0.2 µCi µl-1) to the skin surface of each diffusion 
cell. Samples of receptor fluid (250 µl) were withdrawn from each diffusion cell at regular 
intervals (i.e. every 3 hours) up to 24 hours post exposure and were placed into vials 
containing 5 ml of liquid scintillation counting fluid. Each receptor chamber was replaced 
with an equivalent volume (250 µl) of fresh fluid to maintain a constant volume in the 
receptor chamber. 
Decontamination was conducted 5 minutes post exposure by the addition of a test product 
comprising powder (200 mg), liquid (200 µl) or swab/wipe (5 x 5 cm) to each contaminated 
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skin surface. Each product remained in situ for 24 hours at which point they were removed 
and placed into 20 ml glass vials. Twenty four hours post exposure, test products were 
recovered from each skin surface. The powder or liquid formulations (KBDO-sponge, 
KBDO-liquid, Fuller’s earth, FloraFree, DTAM, Diphotérine, Fast Act and all polymers) 
were placed into glass vials containing 20 ml LSC fluid whereas the wipe, swab or sponge 
formulations (Mmedical sterile swabs, Baby wipes normal and sensitive formulations, 
polymeric sponge formulations; Itaconic acid sponge (IA-SP) and 2-Trifluoromethyl acrylic 
acid sponge (TFMAA-SP)) were placed in 20 ml of isopropanol. The contents of each 
receptor chamber were removed and placed into 20 ml glass vials. Each skin surface was then 
swabbed with a dry gauze pad which was subsequently placed in 20 ml isopropanol. Finally, 
the skin from each diffusion cell was removed and placed into pre-weighed vials. The 
difference in the weight of each vial before and after addition of each skin sample allowed a 
calculation of the skin weight. Each skin sample was then dissolved in 10 ml of Soluene-350.  
All vials were stored at room temperature (with occasional shaking) for up to 5 days after 
which aliquots (250 µl) were removed and placed into vials containing 5 ml LSC fluid. 
Standard solutions were prepared on the day of each experiment by the addition of 2 µl 14C-
radiolabelled methyl salicylate to (a) known weights of fresh test products in 20 ml LSC fluid 
or 20 ml isopropanol, (b) unused gauze pads in 20 ml isopropanol and (c) unexposed skin 
tissue dissolved in 10 ml Soluene-350. Each of the standard solutions was prepared in 
triplicate and was then subject to an identical sampling regime (250 µl aliquots into vials 
containing 5 ml LSC fluid). A standard receptor chamber solution was also prepared in 
triplicate by the addition of 10 µl of 14C-MS, to 990 µl of fresh receptor fluid (50% aqueous 
ethanol) from which a range of triplicate samples (25, 50, 75 and 100µl) were placed into 
vials containing 5 ml of LSC fluid to produce a standard (calibration) curve. Aliquots (250 
µl) of each the samples (i.e., skin, receptor fluid, swabs, and decontaminants) were placed 
into vials containing 5 ml of liquid scintillation fluid and were subject to liquid scintillation 
counting. 
The radioactivity in each sample was quantified using a Perkin Elmer Tri-Carb liquid 
scintillation counter (Model 2810 TR), employing an analysis runtime of 2 minutes per 
sample and a pre-set quench curve specific to the brand of liquid scintillation fluid (Ultima 
Gold™). The amounts of radioactivity in each sample were converted to amount of 14C-
radiolabelled chemical warfare simulant by comparison to the corresponding standards 
(measured simultaneously). Quantification of the amounts of methyl salicylate recovered in 
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each receptor chamber enabled a calculation of the cumulative dermal absorption over 24 
hours. These were averaged at each time point for each treatment group and plotted as total 
amount penetrated (µg cm-2) against time for each experiment. 
In order to permit an inter-experimental comparison of the performance of each treatment, the 
data were normalised relative to controls within each experiment (Equation 1).  
%CD24 =			QT24QC24		×100	    …Equation 1  
Where %CD24 is the percentage of the control dose penetrating the skin, QT24 is the quantity 
of contaminant penetrating the skin at 24 hours following treatment (decontamination) and 
QC24 is the quantity of penetrant penetrating control (untreated) skin at 24 hours. A surrogate 
measure of flux (percentage of control dose penetrating the skin at 3 hours; %CD3) was 
calculated in a similar fashion (by substituting the amount penetrated at 3 hours for that 
penetrated at 24 hours). 
A test for normality (Kolmogorov-Smirnov) was conducted on all data acquired from the in 
vitro studies: the data were found to be not normally distributed (non-Gaussian) and so 
analysed using non-parametric statistical tests. Treatments effects were analysed using the 
non-parametric equivalent of a one way ANOVA (Analysis of variance; KruskalWallis) 
followed by Dunn’s post-test which allow comparisons of each group against a control group.  
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Results 
There was substantial variation in the qualitative performance of the 15 test decontamination 
products: ten 10 reduced the dermal absorption of 14C-MS, one had no demonstrable effect 
and four enhanced absorption (Figure 1). When assessed using the Kruskal-Wallis ANOVA 
with Dunn’s post-test, treatment with Fuller’s earth (FE), D-TAM™, Fast-Act® (FA), 
itaconic acid (IA), 2-trifluoromethylacrylic acid (TFMAA) and N,N-methylene bis 
acrylamide (MBA) caused a statistically significant (p<0.05) reduction in the total amount of 
14C-MS penetrating the skin at 24 hours (expressed as percentage of control dose; %CD24) in 
comparison with their respective controls. 
 Correspondingly, decontamination with FE, IA, TFMAA and MBA resulted in a significant 
decrease in maximum penetration rate (Jmax); Figure 2. In addition, urocanic acid (UA) and 
methacrylic acid (MA) also significantly reduced Jmax (p<0.05), but in the absence of a 
statistically significant effect on %CD24.  
In contrast, sensitive and normal baby-wipes (BW-S and BW-N, respectively) and 
Diphotérine significantly (p<0.05) enhanced both dermal absorption (%CD24; Figure 1) and 
Jmax (Figure 2), whereas medical moist-free wipes (MMFW) and FloraFree™ solution 
significantly (p<0.05) enhanced Jmax only (no significant effect on %CD24).  
No significant effects on Tmax (time at which maximum rate of penetration (Jmax) was 
achieved) were observed for any of the products (Figure 2). 
In terms of recovery of 14C-MS, a wide range (10-80%) of applied dose was sequestered by 
the decontamination products. The majority of products were not significantly different to FE 
in terms of dose recovery. However, FloraFree™, D-TAM™ and Diphotérine were 
significantly (p<0.05) less effective (Table 1).  
All of the polymers (UA, MA, IA) and both baby wipe formulations (BW-S, BW-N) 
significantly reduced the amount of 14C-MS on the skin surface in comparison with 
respective controls (Table 1; p<0.05). All the other test products had no significant effect on 
skin surface recovery.  
Five products (FE, FA, IA, TFMAA and MBA) significantly reduced the amount of 14C-MS 
retained within the skin at 24 hours (Table 1; p<0.05). 
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All experiments resulted in a significant correlation between maximum rate of penetration 
(Jmax) and percentage of control dose at 3 hours (%CD3), r=0.9750, 0.9658 and 0.9887 for 
experiments 1, 2 and 3 respectively (Figure 3; p<0.05).  
When expressed as %CD at 3 versus 24 hours, the baby-wipe formulations (normal & 
sensitive), Diphotérine and 5%FloraFree™ enhanced both the rate and amount penetrated 
(Figure 4; quadrant D). Interestingly, Mmedical moist free wipes led to an increased rate, but 
did not result in higher amounts of 14C-MS penetrating over 24 hours (Figure 4; quadrant C). 
No products enhanced the extent of penetration and decreased the rate of 14C-MS absorption 
(Figure 4; quadrant B).  Of the products which decreased both the rate and extent of 14C-MS 
absorption, IA, MBA, FE, TFMAA and Fast-Act® reduced both %CD3 and %CD24 by 95% 
and 88% respectively. In contrast, D-TAM™, KBDO-L, KBDO-S, MA and UA did not 
perform as well, with the reduction in %CD3 and %CD24 being approximately 70% for either 
parameter. Products delineated by the ring (IA, TFMAA, MA, FE and FA; Figure 4) were the 
top five efficacious products.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 8 of 19
URL: http://mc.manuscriptcentral.com/lcot  Email: awallacehayes@comcast.net
Cutaneous And Ocular Toxicology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
Discussion 
This study has successfully identified a number of effective decontamination products that 
may have potential for use at the scene of a chemical incident. 
The effectiveness of decontaminants was measured in vitro using a static diffusion cell 
system with (previously frozen) skin exposed to radiolabelled contaminants. Whilst this 
model is considered to be appropriate and validated for the assessment of skin absorption (16) 
the corresponding data needs to be interpreted with some caution due to several experimental 
drawbacks of the model. The skin used in these studies was obtained from the dorsal aspect 
of pigs whereas human skin is the skin of choice for assessing dermal absorption. Due to cost 
and availability it was necessary to use a viable alternative. Several animal models have been 
evaluated as to their suitability as a surrogate for human skin (17, 18). Pig skin has been 
shown to have similar histological and morphological properties to human skin (19, 20) and 
is generally more akin to human in terms of permeability to xenobiotics. Skin was excised 
from the dorsal aspect in comparison to porcine ear, the latter being generally more 
comparable with human (21, 22). To reduce animal numbers in accordance with the 3Rs (23), 
the back provided the greatest surface area for dermatoming skin for up to 36 diffusion cells. 
Additionally, skin from one region of the animal may reduce inter-individual variability in 
percutaneous permeability (24, 25), thus allowing statistical differences to be confidently 
attributed to treatment effects. The practice of using previously frozen skin for in vitro dermal 
absorption studies has not been shown to significantly affect penetration (26). The use of 
radiolabelled chemicals in this study also has inherent limitations, as liquid scintillation 
counting cannot distinguish between the parent molecule and its metabolites or hydrolysis 
products. The choice of receptor media will also influence the extent of percutaneous 
absorption of chemical warfare agents and simulants (27). In this study, aqueous ethanol 
(50:50) was chosen to aid partitioning of methyl salicylate, a lipophilic compound (28, 29). 
Whilst there are some concerns over the use of 50% ethanol (aq) in terms of potential ability 
to increase skin permeability (16), it could be argued that an overestimate of dermal 
absorption (if present) would result in a conservative assessment of decontamination and thus 
provide a more rigorous assessment of test products.  This model also lacks physiological 
relevance with regards to metabolic processes, systemic clearance and toxicological end-
points (non-viable skin) (30). Diffusion cell studies are also susceptible to inter and intra-
laboratory variations (31, 32). Despite these drawbacks, in vitro diffusion cells are a useful 
tool and have historically been used for the assessment of percutaneous absorption (33). This 
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model has also been used for similar work assessing product efficacy for decontamination 
(21, 34, 35). Thus overall, the system is well characterised and so the following 
interpretations appear to be justified.  
Initial screening of decontamination products demonstrated that a number of products were 
effective when applied to the skin 5 minutes post exposure. Notably, all of the polymeric 
formulations (IA, TFMAA, MBA) tested were highly effective. The benchmark 
decontaminant (Fuller’s earth; a processed fine powder of natural aluminium silicate clay 
containing an abundance of minerals) removed 83% of 14C-MS which compares favourably 
to the 91% achieved against sulphur mustard on pig ear skin (21). From the total of 15 test 
products, 5 products (Mmedical moist free wipes, 5% FloraFree™ solution, Baby-wipe 
Normal, Baby-wipe Sensitive and Diphotérine) enhanced the rate and amount of penetration, 
thus justifying their elimination from further testing. It is conceivable that water based 
products (i.e. FloraFree™ and Diphotérine) may have enhanced dermal absorption due to the 
‘wash in effect’ (5, 6, 36). Additionally, the baby-wipes may have enhanced penetration due 
to the presence of solvents and or detergents in these wipes as they may have disrupted the 
lipid structure of the stratum corneum and therefore resulted in enhanced penetration (37, 38). 
Of the remaining 10 effective products, 5 (urocanic acid (UA), methacrylic acid (MA), D-
TAM™ and the sponge and liquid KBDO formulations) were discounted as they were 
generally not as effective as FE, Fast-Act®, IA, TFMAA and MBA (Figure 4). Furthermore, 
D-TAM™ was excluded on the basis of the manufacturer’s instructions which contraindicate 
application onto wet skin: a practical point which would clearly limit its use in the UK.  
It is perhaps worth emphasising that the sponge and liquid KBDO formulations were 
specifically designed to decontaminate chemical warfare agents (not methyl salicylate) and 
were not used in accordance with the manufacturer’s instructions (being left on the skin 
rather than immediately removed after application).  A lack of broad spectrum effectiveness 
is considered a disadvantage.  However, the main constituent of KBDO liquid is polyethylene 
glycol, the primary function of which is to solubilise contaminants within the lotion (39). 
Indeed, PEG may contribute to the generic effectiveness of such decontamination products 
through preferential partitioning of contaminants (40). 
A strong correlation between %CD3 and Jmax was obtained (Figure 3) indicating that %CD3 is 
a good surrogate for measuring skin absorption kinetics. The use of %CD3 in future studies 
could provide practical benefit in reducing the frequency of receptor chamber samples 
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required to characterise the performance of a decontamination product. More importantly, 
%CD3 eliminates the inherent variation in skin permeability between different skin samples. 
Normalising the Jmax values (using %CD3) allows the performance of all products to be 
directly compared regardless of the experiment-specific differences in skin permeability. 
Further work is required to fully evaluate the 5 most effective products, consisting of one 
military product (Fuller’s earth), one commercial off the shelf product (Fast Act®) and three 
novel polymers (Itaconic acid, N,N-Methylene Bis Acrylamide and 2-Trifluoromethylacrylic 
acid) against chemical warfare agents: sulphur mustard (HD), soman (GD) and VX. 
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Experiment Treatment Skin Skin 
Surface 
Decontaminant Receptor 
Fluid 
1 
Control 9.2 ± 1.8 0.9 ± 0.5 NA 3.1 ± 1.2 
Fuller’s Earth 0.4 ± 0.7
§
 0.1 ± 0.1 83.0 ± 10.9 0.1 ± 0.2 
Medical moist 
free wipes 
2.1 ± 3.9 0.1 ± 0.1 28.0 ± 11.6 2.5 ± 1.4 
KBDO 
Sponges 
4.4 ± 5.3 1.7 ± 2.0 36.8 ± 43.3 0.3 ± 0.3 
KBDO Liquid 4.1 ± 2.8 4.6 ± 1.1 18.9 ± 23.0 0.4 ± 0.2 
5% Florafree 6.7 ± 2.5 1.6 ± 0.5 2.4 ± 2.1
*
 4.6 ± 1.9 
2 
Control 8.0 ± 3.9 3.7 ± 1.4 NA 2.5 ± 1.2 
DTAM 2.9 ± 2.4 4.2 ± 3.5 12.1 ± 18.7
*
 0.5 ± 0.1 
Baby-wipe 
Sensitive 
1.7 ± 0.3 0.7 ± 0.2
#
 19.5 ± 6.6 10.1 ± 5.5 
Diphotérine 12.0 ± 7.3 1.0 ± 0.4 2.2 ± 2.5
*
 6.2 ± 3.4 
Baby-wipe 
Normal 
4.8 ± 6.2 0.6 ± 0.1
#
 20.0 ± 11.5 8.4 ± 1.4 
Fast Act 0.9 ± 0.6
§
 0.7 ± 0.6 49.5 ± 15.1 0.0 ± 0.0 
3 
Control 16.3 ± 7.7 3.9 ± 2.0 NA 4.3 ± 1.4 
IA 0.9 ± 1.3
§
 0.3 ± 0.2
#
 81.8 ± 21.3 0.2 ± 0.3 
TFMAA 0.1 ± 0.0
§
 0.2 ± 0.1
#
 71.0 ± 28.3 0.1 ± 0.1 
MBA 0.5 ± 0.9
§
 0.2 ± 0.1
#
 98.5 ± 40.6 0.2 ± 0.3 
UA 1.0 ± 1.4 0.3 ± 0.2
#
 77.0 ± 43.5 0.4 ± 0.4 
MA 1.9 ± 1.6 0.5 ± 0.3
#
 79.4 ± 6.9 0.5 ± 0.4 
 
Table 1: Dose distribution on the percentage of dose applied of 
14
C-Radiolabelled methyl 
salicylate penetrating untreated (control) or decontaminated pig skin over a 24 hour 
period. Skin surface decontamination was conducted five minutes post-exposure using Baby-
wipe Normal, Baby-wipe Sensitive, Diphotérine , FloraFree™ detergent, Medical moist free 
wipes, D-TAM™, KBDO liquid, KBDO sponge, Methacrylic acid (MA), Urocanic acid (UA), 
N,N-Methylene Bis Acrylamide (MBA), Fast-Act®,2-Trifluoromethylacrylic acid (TFMAA), 
Fuller’s earth and Itaconic acid (IA). All points are mean ± standard deviation of up to n=6 
diffusion cells. Porcine skin was obtained from the dorsum of one animal. Section symbol (§) 
indicates significant reductions (p<0.05) in the amount of 
14
C-MS remaining within the skin 
at 24 hours compared to controls (untreated) skin. Hash symbol (#) indicates significant 
(p<0.05) reductions on amount remaining on skin surface against respective controls. 
Asterisk (*) indicates recovery of 
14
C-MS from decontaminant was significantly different 
(p<0.05) to FE. 
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Figure 1: Cumulative amount of 
14
C-Radiolabelled methyl salicylate penetrating untreated 
(control) or decontaminated pig skin over a 24 hour period. 10µl of 14C-methyl salicylate (2µCi total 
per cell) was applied to the skin surface. Skin surface decontamination was conducted five minutes 
post-exposure using Fuller’s earth, Medical moist frees wipe (MMFW), Potassium butadione 
monoximate (KBDO) Sponge, KBDO liquid and 5% FloraFree™ detergent solution (A), D-TAM™ 
skin cleanser, Baby-wipe Sensitive, Diphotérine , Baby-wipe Normal, Fast-Act®, (B), Itaconic acid 
(IA), 2-Trifluoromethylacrylic acid (TFMAA), N,N-Methylene Bis Acrylamide (MBA), Urocanic acid 
(UA) and Methacrylic acid (MA  (C). Asterisk (*) indicates significant (p<0.05) reductions in amount 
penetrated at 24 hours compared to control. All points are mean ± standard deviation of up to n=6 
diffusion cells. Porcine skin was obtained from the dorsum of one animal. 
Control
Fullers Earth
MMFW
KBDO-S
KBDO-L
5% Florafree
Control
DTAM
Babywipe-S
Diphoterine
Babywipe-N
Fast Act
Control
IA
TFMAA
MBA
UA
MA
%CD24
1.8 ± 0.8 *
73.4 ± 22.3
12.4 ± 10.3
12.8 ± 7.8
144.8 ± 41.9
%CD24
25.0 ± 13.0 *
424.5 ± 46.8
336.7 ± 95.0
448.0 ± 166.6
2.3 ± 1.3 *
%CD24
1.1 ± 1.2 *
2.1 ± 1.3 *
1.7 ± 0.5 *
8.3 ± 9.9
11.7 ± 8.3 
0
50
100
150
200
250
300
350
400
0 3 6 9 12 15 18 21 24
Time (h)
A
m
o
u
n
t 
P
e
n
e
tr
a
te
d
 (
µ
g
 c
m
-2
)
0
100
200
300
400
500
600
700
800
0 3 6 9 12 15 18 21 24
Time (h)
A
m
o
u
n
t 
P
e
n
e
tr
a
te
d
 (
µ
g
 c
m
-2
)
0
50
100
150
200
250
300
350
400
0 3 6 9 12 15 18 21 24
Time (h)
A
m
o
u
n
t 
P
e
n
e
tr
a
te
d
 (
µ
g
 c
m
-2
)
Page 16 of 19
URL: http://mc.manuscriptcentral.com/lcot  Email: awallacehayes@comcast.net
Cutaneous And Ocular Toxicology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only  
 
Figure 2: Flux profile of 
14
C-Radiolabelled methyl salicylate penetrating untreated (control) or 
decontaminated pig skin over a 24 hour period. 10µl of 
14
C-methyl salicylate (2µCi total per cell) 
was applied to the skin surface. Skin surface decontamination was conducted five minutes post-
exposure using Fuller’s earth, Medical moist frees wipe (MMFW), Potassium butadione monoximate 
(KBDO) Sponge, KBDO liquid and 5% FloraFree™ detergent solution (A), D-TAM™ skin cleanser, 
Baby-wipe Sensitive, Diphotérine , Baby-wipe Normal, Fast-Act®, (B), Itaconic acid (IA), 2-
Trifluoromethylacrylic acid (TFMAA), N,N-Methylene Bis Acrylamide (MBA), Urocanic acid (UA) 
and Methacrylic acid (MA  (C). Asterisk and hash (* & #) indicates significant (p<0.05) reductions 
and enhancements in Jmax compared to control respectively. All points are mean ± standard deviation 
of up to n=6 diffusion cells. Porcine skin was obtained from the dorsum of one animal. 
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Figure 3: Comparison of maximum rate of penetration (Jmax µg/cm
2
/h) against surrogate 
marker for rate of penetration (%CD3; see equation 1). Each data point is n=1 diffusion 
cells for each of the treatments for the respective experiments totalling n=36. 
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Figure 4: Summary of decontaminants evaluated against 
14
C-methyl salicylate normalised 
as percentage control dose at 3 and 24 hours (%CD3 and %CD24) plotted on a log scale for 
clarity. Skin surface decontamination was conducted five minutes post-exposure using Baby-
wipe Normal, Baby-wipe Sensitive, Diphotérine , FloraFree™ detergent, Medical moist free 
wipes, D-TAM™, KBDO liquid, KBDO sponge, Methacrylic acid (MA), Urocanic acid (UA), 
N,N-Methylene Bis Acrylamide (MBA), Fast-Act®,2-Trifluoromethylacrylic acid (TFMAA), 
Fuller’s earth and Itaconic acid (IA). All points are mean ± standard deviation of up to n=6 
diffusion cells. Porcine skin was obtained from the dorsum of one animal. Quadrant A shows 
products which reduced the rate and amount penetrated. Quadrant B shows products that 
reduced rate, however resulted in no change to amount penetrating at 24 hours. Conversely 
C shows opposite effects (Reduced amount penetrating at 24 hours, increased rate of 
penetration). Quadrant D defines products which have increased both rate and amount 
penetrating the skin. Products delineated by a ring were the five most effective. 
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